MER511

· Merida Biosciences

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MER511, covering 2026-04-24 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: NEXUS Study: A Study to Test Single and Multiple Doses of MER511 Given to Adults With Graves' Disease [Phase 1]